The new TurboVap® LV, II and EH systems incorporate many new customer driven features and enable end users to switch quickly between the functionality they are presently accustomed to in the classic instruments. Each system has enhanced visibility, a compact design, removable/adjustable nozzles, exchangeable manifolds, evaporation flow gradients, and a touch screen interface.
The TurboVap® EH system is seamlessly integrated with the Biotage® Extrahera™ and is aesthetically very similar, with similar internal lighting, glass sides and a glass lid, greatly improving sample visibility. In parallel, Biotage are introducing a series of Multi-Racks that offer greater flexibility in the variety of different tube and vial sizes that can be processed. Each system of course still has the highly efficient patented gas vortex shearing technology, which is synonymous with the TurboVap® brand.
“Our new TurboVap® enhanced evaporation systems, are built on the reliability and performance associated with the TurboVap name. The new systems will increase laboratory efficiency, improve the cost of analysis and enable improved user control of the evaporation process” said Mr. Paul Roberts, Global Product Manager, Analytical Consumables and Systems, Biotage.
For further information visit www.biotage.com or call: in Europe +46 18 56 57 10, in North America toll free 1 800 446 4752, in Japan +81 3 5627 3123, other areas please call +46 18 56 57 10.
For further press information from Biotage please contact: James Churchill, Marketing Communications Manager, Biotage GB Ltd. Distribution Way, Dyffryn Business Park, Ystrad Mynach, Hengoed, Wales CF82 7TS United Kingdom. Tel: +44 (0)1443 811 849. Mobile: +44 (0) 7875 484778. Email: email@example.com
Biotage offers solutions, knowledge and experience in the areas of analytical and medicinal chemistry. Customers include the world’s top pharmaceutical and biotechnology companies, as well as leading academic institutes. The company is headquartered in Uppsala, Sweden, with offices in South Korea, China, Japan, the United Kingdom, the United States and a worldwide network of distributors. Biotage approximately 300 employees, with sales of 667 MSEK in 2016. Biotage is listed on the NASDAQ OMX Nordic Stock Exchange.
How to Identify Compounds in a Mass Spectrum
Release of EVOLUTE® HYDRO SPE Plates with Integral Hydrolysis Capability
Biotage Goes Direct in Italy
New Peptide Synthesis Workflow Brochure
Extraction of Plasma Catecholamines and Metanephrines Using EVOLUTE® EXPRESS WCX SPE Prior to LC-MS/MS Analysis